标题
Advances in lipid-lowering therapy through gene-silencing technologies
作者
关键词
-
出版物
Nature Reviews Cardiology
Volume 15, Issue 5, Pages 261-272
出版商
Springer Nature
发表日期
2018-02-08
DOI
10.1038/nrcardio.2018.3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease
- (2017) Amit V. Khera et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Test in Context: Lipid Profile, Fasting Versus Nonfasting
- (2017) Børge G. Nordestgaard JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2017) Mohsen Naghavi et al. LANCET
- Revisiting biomarker discovery by plasma proteomics
- (2017) Philipp E Geyer et al. Molecular Systems Biology
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia
- (2017) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides
- (2017) Mark J. Graham et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Highly Durable RNAi Therapeutic Inhibitor of PCSK9
- (2017) Kevin Fitzgerald et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
- (2017) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
- (2017) Frederick E. Dewey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Effects of 2′-O-Methoxyethyl Containing Antisense Oligonucleotides on Platelets in Human Clinical Trials
- (2017) Stanley T. Crooke et al. Nucleic Acid Therapeutics
- Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics
- (2017) Yuanyu Huang Molecular Therapy-Nucleic Acids
- Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease
- (2016) Børge G. Nordestgaard CIRCULATION RESEARCH
- Increased Remnant Cholesterol Explains Part of Residual Risk of All-Cause Mortality in 5414 Patients with Ischemic Heart Disease
- (2016) A.-M. K. Jepsen et al. CLINICAL CHEMISTRY
- Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints--A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
- (2016) B. G. Nordestgaard et al. CLINICAL CHEMISTRY
- Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes
- (2016) Andres Digenio et al. DIABETES CARE
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- (2016) Massimo F. Piepoli et al. EUROPEAN HEART JOURNAL
- 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
- (2016) Alberico L. Catapano et al. EUROPEAN HEART JOURNAL
- Anti-sense oligonucleotide therapies for the treatment of hyperlipidaemia
- (2016) Anthony S. Wierzbicki et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients
- (2016) Stephen J. Nicholls et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Long-term mipomersen treatment is associated with a reduction in cardiovascular events in patients with familial hypercholesterolemia
- (2016) P. Barton Duell et al. Journal of Clinical Lipidology
- Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology
- (2016) Børge G. Nordestgaard et al. JOURNAL OF LIPID RESEARCH
- Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase
- (2016) Peter Würtz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
- (2016) Nicholas J Viney et al. LANCET
- Alnylam terminates revusiran program, stock plunges
- (2016) Ken Garber NATURE BIOTECHNOLOGY
- Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease
- (2016) Anna Helgadottir et al. NATURE GENETICS
- From the RNA world to the clinic
- (2016) B. A. Sullenger et al. SCIENCE
- Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans
- (2016) Gissette Reyes-Soffer et al. Science Translational Medicine
- Nonfasting Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis
- (2016) Simon B. Pedersen et al. JAMA Internal Medicine
- Extreme Nonfasting Remnant Cholesterol vs Extreme LDL Cholesterol as Contributors to Cardiovascular Disease and All-Cause Mortality in 90000 Individuals from the General Population
- (2015) A. Varbo et al. CLINICAL CHEMISTRY
- Gene-based therapies in lipidology
- (2015) Daniel Gaudet et al. CURRENT OPINION IN LIPIDOLOGY
- An overview of the clinical application of antisense oligonucleotides for RNA-targeting therapies
- (2015) Graham McClorey et al. CURRENT OPINION IN PHARMACOLOGY
- Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
- (2015) Albert Wiegman et al. EUROPEAN HEART JOURNAL
- Efficacy and safety of mipomersen in treatment of dyslipidemia: A meta-analysis of randomized controlled trials
- (2015) Raju Panta et al. Journal of Clinical Lipidology
- Serum lipoprotein (a) concentrations are inversely associated with T2D, prediabetes, and insulin resistance in a middle-aged and elderly Chinese population
- (2015) Lin Ding et al. JOURNAL OF LIPID RESEARCH
- Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
- (2015) Michael B. Boffa et al. JOURNAL OF LIPID RESEARCH
- Antisense inhibition of apolipoprotein (a) to lower plasma lipoprotein (a) levels in humans
- (2015) Mark J. Graham et al. JOURNAL OF LIPID RESEARCH
- Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study
- (2015) Sotirios Tsimikas et al. LANCET
- Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
- (2015) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms of Plaque Formation and Rupture
- (2014) Jacob Fog Bentzon et al. CIRCULATION RESEARCH
- Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
- (2014) M. Cuchel et al. EUROPEAN HEART JOURNAL
- Liver histology during Mipomersen therapy for severe hypercholesterolemia
- (2014) Nikroo Hashemi et al. Journal of Clinical Lipidology
- Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing
- (2014) Jayaprakash K. Nair et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Triglycerides and cardiovascular disease
- (2014) Børge G Nordestgaard et al. LANCET
- Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
- (2014) Anders Berg Jørgensen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting APOC3 in the Familial Chylomicronemia Syndrome
- (2014) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Targeted delivery of antisense oligonucleotides to hepatocytes using triantennaryN-acetyl galactosamine improves potency 10-fold in mice
- (2014) Thazha P. Prakash et al. NUCLEIC ACIDS RESEARCH
- Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation
- (2013) Anette Varbo et al. CIRCULATION
- Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans
- (2013) Mark J. Graham et al. CIRCULATION RESEARCH
- The Association Between Circulating Lipoprotein(a) and Type 2 Diabetes: Is It Causal?
- (2013) Z. Ye et al. DIABETES
- Lipoprotein(a): resurrected by genetics
- (2013) F. Kronenberg et al. JOURNAL OF INTERNAL MEDICINE
- Elevated Lipoprotein(a) and Risk of Aortic Valve Stenosis in the General Population
- (2013) Pia R. Kamstrup et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genetic Associations with Valvular Calcification and Aortic Stenosis
- (2013) George Thanassoulis et al. NEW ENGLAND JOURNAL OF MEDICINE
- A prospective cohort study on risk of acute pancreatitis related to serum triglycerides, cholesterol and fasting glucose
- (2013) Björn Lindkvist et al. PANCREATOLOGY
- Antisense Technology: An Emerging Platform for Cardiovascular Disease Therapeutics
- (2013) Richard G. Lee et al. Journal of Cardiovascular Translational Research
- Lipoprotein(a) concentrations, isoform size, and risk of type 2 diabetes: a Mendelian randomisation study
- (2013) Pia R Kamstrup et al. Lancet Diabetes & Endocrinology
- The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
- (2013) Robert A Hegele et al. Lancet Diabetes & Endocrinology
- RNA-Based Therapeutics: Current Progress and Future Prospects
- (2012) John C. Burnett et al. CHEMISTRY & BIOLOGY
- Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction
- (2012) Anders Berg Jørgensen et al. EUROPEAN HEART JOURNAL
- Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
- (2012) Lars Berglund et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
- (2012) Anette Varbo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol
- (2012) Evan A. Stein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inverse association between serum lipoprotein(a) and cerebral hemorrhage in the Japanese population
- (2012) Shizukiyo Ishikawa et al. THROMBOSIS RESEARCH
- Hypertriglyceridemia and Acute Pancreatitis
- (2012) Michael J. Murphy et al. JAMA Internal Medicine
- Triglycerides and Cardiovascular Disease
- (2011) Michael Miller et al. CIRCULATION
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
- (2011) M. John Chapman et al. EUROPEAN HEART JOURNAL
- Silencing disease genes in the laboratory and the clinic
- (2011) Jonathan K Watts et al. JOURNAL OF PATHOLOGY
- Pancreatitis in Hyperlipemic Mink (Mustela vison)
- (2011) K. Nordstoga et al. VETERINARY PATHOLOGY
- RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
- (2010) C. Frank Bennett et al. Annual Review of Pharmacology and Toxicology
- Lipoprotein(a) and Risk of Type 2 Diabetes
- (2010) S. Mora et al. CLINICAL CHEMISTRY
- Lipoprotein(a) as a cardiovascular risk factor: current status
- (2010) Børge G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- PCSK9R46L, Low-Density Lipoprotein Cholesterol Levels, and Risk of Ischemic Heart Disease
- (2010) Marianne Benn et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
- (2010) Frederick J Raal et al. LANCET
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
- (2009) Pia R. Kamstrup JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
- (2009) Robert Clarke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started